Literature DB >> 19560788

Reversible metronidazole-induced cerebellar toxicity in a multiple transplant recipient.

Tracey D Graves1, Marie Condon, Marina Loucaidou, Richard J Perry.   

Abstract

Metronidazole-induced central nervous system (CNS) toxicity causes a spectrum of neurological symptoms including ataxia, encephalopathy and peripheral neuropathy. It is associated with characteristic MRI changes of high signal intensity in the dentate nuclei. Given the increasing use of metronidazole, it is import to recognise this drug as a cause of ataxia, as it is entirely reversible on drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560788     DOI: 10.1016/j.jns.2009.06.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

3.  Metronidazole-induced reversible encephalopathy in a patient with facioscapulohumeral muscular dystrophy.

Authors:  Athanasios Papathanasiou; Vasiliki Zouvelou; Stavroula Kyriazi; Michael Rentzos; Ioannis Evdokimidis
Journal:  Clin Neuroradiol       Date:  2012-08-19       Impact factor: 3.649

4.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

5.  Metronidazole induced encephalopathy in a patient with brain abscess.

Authors:  Yoochang Bahn; Eunyoung Kim; Chongoon Park; Hyung-Chun Park
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

6.  Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis.

Authors:  Mark S Godfrey; Arkadiy Finn; Hadeel Zainah; Kwame Dapaah-Afriyie
Journal:  BMJ Case Rep       Date:  2015-01-16

Review 7.  Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature.

Authors:  Ujjawal Roy; Ajay Panwar; Alak Pandit; Susanta Kumar Das; Bhushan Joshi
Journal:  J Clin Diagn Res       Date:  2016-06-01

8.  Metronidazole-induced encephalopathy in a patient with end-stage liver disease.

Authors:  John P Knorr; Imran Javed; Neha Sahni; Ceylan Z Cankurtaran; Jorge A Ortiz
Journal:  Case Reports Hepatol       Date:  2012-12-17

9.  Metronidazole-Induced Cerebellar Toxicity.

Authors:  Amit Agarwal; Sangam Kanekar; Shyam Sabat; Krishnamurthy Thamburaj
Journal:  Neurol Int       Date:  2016-04-01

10.  Metronidazole-induced encephalopathy in a patient with pyogenic spondylitis: a case report.

Authors:  Kazutaka Mizuta; Motoki Sonohata; Osamu Nozaki; Tomoki Kobatake; Daisuke Nakayama; Tadatsugu Morimoto; Masaaki Mawatari
Journal:  BMC Musculoskelet Disord       Date:  2018-09-18       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.